LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 45.25 | 84.90 | 199 | 4539 | 0.0438 | 0.1600 | MN20160318_Q02 | E22 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 45.25 | 84.90 | 3006 | 4539 | 0.6621 | 0.8614 | MN20160318_Q02 | E22 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 45.25 | 84.90 | 453 | 4539 | 0.0998 | 0.3387 | MN20160318_Q02 | N21 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 45.25 | 84.90 | 3314 | 4539 | 0.7300 | 0.8933 | MN20160318_Q02 | N21 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 46.95 | 84.90 | 194 | 4952 | 0.0392 | 0.1513 | MN20160318_Q02 | E22 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 46.95 | 84.90 | 3125 | 4952 | 0.6310 | 0.8490 | MN20160318_Q02 | E22 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 46.95 | 84.90 | 498 | 4952 | 0.1006 | 0.3520 | MN20160318_Q02 | N21 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 46.95 | 84.90 | 3472 | 4952 | 0.7011 | 0.8825 | MN20160318_Q02 | N21 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 48.65 | 84.90 | 205 | 5328 | 0.0385 | 0.1591 | MN20160318_Q02 | E22 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 48.65 | 84.90 | 3312 | 5328 | 0.6215 | 0.8469 | MN20160318_Q02 | E22 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 48.65 | 84.90 | 526 | 5328 | 0.0987 | 0.3572 | MN20160318_Q02 | N21 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 48.65 | 84.90 | 3670 | 5328 | 0.6887 | 0.8789 | MN20160318_Q02 | N21 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 50.36 | 84.90 | 238 | 5651 | 0.0421 | 0.1855 | MN20160318_Q02 | E22 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 50.36 | 84.90 | 3434 | 5651 | 0.6077 | 0.8421 | MN20160318_Q02 | E22 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 50.36 | 84.90 | 540 | 5651 | 0.0956 | 0.3573 | MN20160318_Q02 | N21 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 50.36 | 84.90 | 3824 | 5651 | 0.6767 | 0.8751 | MN20160318_Q02 | N21 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 52.06 | 84.90 | 258 | 5990 | 0.0431 | 0.1984 | MN20160318_Q02 | E22 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 52.06 | 84.90 | 3643 | 5990 | 0.6081 | 0.8444 | MN20160318_Q02 | E22 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 52.06 | 84.90 | 606 | 5990 | 0.1012 | 0.3772 | MN20160318_Q02 | N21 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 52.06 | 84.90 | 3993 | 5990 | 0.6665 | 0.8721 | MN20160318_Q02 | N21 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 53.77 | 84.90 | 283 | 6252 | 0.0453 | 0.2142 | MN20160318_Q02 | E22 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 53.77 | 84.90 | 3793 | 6252 | 0.6066 | 0.8452 | MN20160318_Q02 | E22 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 53.77 | 84.90 | 626 | 6252 | 0.1001 | 0.3800 | MN20160318_Q02 | N21 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 53.77 | 84.90 | 4111 | 6252 | 0.6575 | 0.8693 | MN20160318_Q02 | N21 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 55.48 | 84.90 | 274 | 6567 | 0.0417 | 0.2054 | MN20160318_Q02 | E22 |